Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act

Sam  Craft; Michael Dunn; Dan Vidler; Jane Officer; Ian S.  Blagbrough; Christopher R.  Pudney; Graeme  Henderson; Ahmed  Abouzeid; Paul I Dargan; Michael Eddleston; Jamie  Cooper; Simon L Hill; Clair  Roper; Tom P Freeman; Simon H L Thomas

doi:10.1111/add.15967

Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act

Sam Craft, Michael Dunn, Dan Vidler, Jane Officer, Ian S. Blagbrough, Christopher R. Pudney, Graeme Henderson, Ahmed Abouzeid, Paul I Dargan, Michael Eddleston, Jamie Cooper, Simon L Hill, Clair Roper, Tom P Freeman, Simon H L Thomas

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Addiction
Early online date	6 Jun 2022
DOIs	https://doi.org/10.1111/add.15967
Publication status	E-pub ahead of print - 6 Jun 2022

Access to Document

10.1111/add.15967

Embargoed Document

IONA_SCRA_PSA_Accepted
Accepted author manuscript, 321 KB
Embargo ends: 6/06/23

Cite this

Craft, S., Dunn, M., Vidler, D., Officer, J., Blagbrough, I. S., Pudney, C. R., Henderson, G., Abouzeid, A., Dargan, P. I., Eddleston, M., Cooper, J., Hill, S. L., Roper, C., Freeman, T. P., & Thomas, S. H. L. (2022). Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. Addiction. https://doi.org/10.1111/add.15967

Craft, Sam ; Dunn, Michael ; Vidler, Dan ; Officer, Jane ; Blagbrough, Ian S. ; Pudney, Christopher R. ; Henderson, Graeme ; Abouzeid, Ahmed ; Dargan, Paul I ; Eddleston, Michael ; Cooper, Jamie ; Hill, Simon L ; Roper, Clair ; Freeman, Tom P ; Thomas, Simon H L. / Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. In: Addiction. 2022.

@article{1147a3e791ca4eba809ea5d1ce630703,

title = "Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act",

author = "Sam Craft and Michael Dunn and Dan Vidler and Jane Officer and Blagbrough, {Ian S.} and Pudney, {Christopher R.} and Graeme Henderson and Ahmed Abouzeid and Dargan, {Paul I} and Michael Eddleston and Jamie Cooper and Hill, {Simon L} and Clair Roper and Freeman, {Tom P} and Thomas, {Simon H L}",

note = "Funding Information: The IONA study was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) for Chemical and Radiation Threats and Hazards at Newcastle University. This work was supported in part by MR/N0137941/1 for the GW4 BIOMED MRC DTP, awarded to the Universities of Bath, Bristol, Cardiff and Exeter from the Medical Research Council (MRC)/UKRI. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, Public Health England or the MRC. Funding information Publisher Copyright: {\textcopyright} 2022 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.",

year = "2022",

month = jun,

day = "6",

doi = "10.1111/add.15967",

language = "English",

journal = "Addiction",

issn = "0965-2140",

publisher = "Wiley",

}

Craft, S, Dunn, M, Vidler, D, Officer, J, Blagbrough, IS, Pudney, CR, Henderson, G, Abouzeid, A, Dargan, PI, Eddleston, M, Cooper, J, Hill, SL, Roper, C, Freeman, TP & Thomas, SHL 2022, 'Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act', Addiction. https://doi.org/10.1111/add.15967

Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act. / Craft, Sam ; Dunn, Michael; Vidler, Dan; Officer, Jane; Blagbrough, Ian S. ; Pudney, Christopher R. ; Henderson, Graeme ; Abouzeid, Ahmed ; Dargan, Paul I; Eddleston, Michael; Cooper, Jamie ; Hill, Simon L; Roper, Clair ; Freeman, Tom P; Thomas, Simon H L.

In: Addiction, 06.06.2022.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Trends in hospital presentations following analytically confirmed synthetic cannabinoid receptor agonist exposure before and after implementation of the 2016 UK Psychoactive Substances Act

AU - Craft, Sam

AU - Dunn, Michael

AU - Vidler, Dan

AU - Officer, Jane

AU - Blagbrough, Ian S.

AU - Pudney, Christopher R.

AU - Henderson, Graeme

AU - Abouzeid, Ahmed

AU - Dargan, Paul I

AU - Eddleston, Michael

AU - Cooper, Jamie

AU - Hill, Simon L

AU - Roper, Clair

AU - Freeman, Tom P

AU - Thomas, Simon H L

N1 - Funding Information: The IONA study was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) for Chemical and Radiation Threats and Hazards at Newcastle University. This work was supported in part by MR/N0137941/1 for the GW4 BIOMED MRC DTP, awarded to the Universities of Bath, Bristol, Cardiff and Exeter from the Medical Research Council (MRC)/UKRI. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, Public Health England or the MRC. Funding information Publisher Copyright: © 2022 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

PY - 2022/6/6

Y1 - 2022/6/6

U2 - 10.1111/add.15967

DO - 10.1111/add.15967

M3 - Article

JO - Addiction

JF - Addiction

SN - 0965-2140

ER -